Biolinco
PrivateLast Round
Accelerator
Mar 9, 2026
Total Funding Raised
$232,500
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biolinco operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was an Accelerator round in March 2026.
Biolinco is a healthcare technology company that provides a biopharmaceutical therapies platform designed to reduce the cost of biomanufacturing by increasing drug yields.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolinco Comparables
Compare Biolinco with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evotec | 71% | |
| Asimov | 70% | |
| GenScript | 69% |
For institutional investors. Book with your work email.
Biolinco Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 9, 2026 | ||||
| Grant | Jun 4, 2024 |
For institutional investors. Book with your work email.
Biolinco Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| Johns Hopkins University Endowment | Accelerator, Grant |
| HopStone Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 108% MoM.
- Mar 9, 2026
$220K round led by Techstars
For institutional investors. Book with your work email.
Biolinco Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biolinco's valuation, stock price, and market status.
Is Biolinco a public or private company?
Biolinco is a private company.
What is the current stock price of Biolinco?
Biolinco is a private company, so its shares have no public market price. Caplight tracks Biolinco's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biolinco worth (valuation)?
Valuation information for Biolinco is not publicly available.
Can I buy Biolinco stock?
Biolinco shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biolinco's last funding round?
Biolinco's most recent funding round was Accelerator on March 9, 2026.
Who are the main investors in Biolinco?
Key investors in Biolinco include Techstars.
Will Biolinco IPO soon?
No public IPO plans have been announced for Biolinco.
How can I track Biolinco secondary market activity?
Caplight tracks bids, offers, and trades in Biolinco's shares on secondary markets.